Biotest AG

https://www.biotest.de

Biotest is a provider of plasma proteins and biological drugs. With a value added chain that extends from pre-clinical and clinical development to worldwide sales, Biotest has specialised primarily in the areas of clinical immunology, haematology and intensive medicine. Biotest develops and markets immunoglobulins, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and haematopoietic systems. In addition Biotest develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus which are produced by recombinant technologies. Biotest has more than 2,500 employees worldwide. The preference shares of Biotest AG are listed in the SDAX on the Frankfurt stock exchange. *

	Start	1946-01-01 established
	Group	Grifols (Group)
	Industry	pharmaceutical
	Industry 2	diagnostics (medical/biological)
	Person	Schulz, Gregor (Biotest 201212 CEO)
	Person 2	Ramroth, Michael (Biotest 201301 CFO)

	Region	Dreieich
	Country	Germany
	Street	5 Landsteinerstr.
	City	63303 Dreieich
	Tel	+49-6103 -801-338
		Address record changed: 2020-12-02

Basic data	Employees	F: 1,001 to 5,000 (2023-12-31)
	Currency	EUR
	Annual sales	684,600,000 (sales, consolidated (2023) 2023-12-31)
	Profit	127,000,000 (2023-12-31)
	Cash	108,100,000 (2023-12-31)

		* Document for »About Section«:

		Record changed: 2024-12-29